비만 치료 제품 시장 : 제품, 기술, 최종사용자별 - 세계 예측(2025-2030년)

The Bariatric Products Market was valued at USD 4.92 billion in 2023, expected to reach USD 5.22 billion in 2024, and is projected to grow at a CAGR of 7.60%, to USD 8.22 billion by 2030.

The bariatric products market encompasses a range of medical devices, implants, and nutritional supplements used primarily to support weight loss surgery and post-surgical care. These include adjustable gastric bands, gastric balloons, biliopancreatic diversion devices, and dietary supplements specifically designed for bariatric patients. The necessity for these products arises due to increasing obesity rates worldwide, leading to higher demand for bariatric surgeries as a viable solution for weight management and related co-morbidities such as diabetes, hypertension, and cardiovascular diseases. The application of these products spans from pre-surgical support to enhance procedure success rates to long-term patient management to ensure sustained weight loss and improved health outcomes. End-users mainly include hospitals, bariatric surgical centers, and home care settings. Key growth factors influencing this market include the rising prevalence of obesity, advancements in minimally invasive surgery techniques, and increasing awareness and acceptance of bariatric surgeries as a treatment solution. The latest market opportunities are embedded in emerging markets where obesity rates are increasing, thereby driving demand for bariatric solutions. To tap into these opportunities, market players should focus on cost-effective solutions and patient-friendly products that cater to both high-income and emerging economies. However, limitations such as high costs of procedures, reimbursement challenges, and potential surgical complications pose challenges to market growth. Market innovation could best be pursued in developing advanced, non-invasive devices, personalized nutrition plans, and digital health integration through telemedicine platforms to enhance patient monitoring and follow-up care. Additionally, investing in research to build long-term efficacy and safety data can further legitimize bariatric procedures and their associated products. The bariatric products market is characterized by a strong drive for technological advancements and patient-centered solutions, making it competitive yet ripe for innovation. Addressing affordability, accessibility, and patient education will be crucial for future growth and market expansion.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bariatric Products Market

The Bariatric Products Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of obesity and related health conditions
  • Supportive government policies and insurance coverage for bariatric surgeries and related treatments
• Market Restraints
  • High cost of bariatric procedures and products, along with limited awareness
• Market Opportunities
  • Innovations and investments in biotechnology and non-invasive treatments
  • Expanding collaborations between healthcare providers and tech companies
• Market Challenges
  • Risk of complications and side effects associated with bariatric procedures and products

Porter's Five Forces: A Strategic Tool for Navigating the Bariatric Products Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bariatric Products Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bariatric Products Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bariatric Products Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bariatric Products Market

A detailed market share analysis in the Bariatric Products Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bariatric Products Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bariatric Products Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bariatric Products Market

A strategic analysis of the Bariatric Products Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bariatric Products Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AMI GmbH, Apollo Endosurgery, Inc., Asensus Surgical, Inc., B. Braun SE, BIOTRONIK SE & Co KG, Boston Scientific Corporation, CONMED Corporation, Cousin Biotech, Edwards Lifesciences, Geyi Medical Instrument, GI Dynamics Inc., Grena Ltd., Integra LifeSciences Corporation, Intuitive Surgical Inc., Johnson & Johnson Private Limited, Mediflex Surgical Products, Medtronic PLC, Olympus Corporation, ReShape Lifesciences, Inc., Spatz FGIA, Inc., Standard Bariatrics, Inc., Stryker Corporation, USGI Medical Inc., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Bariatric Products Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Gastric Balloons, Gastric Bands, Gastric Bypass Devices, Gastric Electrical Stimulation Devices, and Gastric Emptying Devices.
• Based on Technology, market is studied across Adjustable Gastric Banding, Endoscopic Suturing Device, Gastric Positioning Device, Intragastric Balloon Mostly-Air Filled Device, and Intragastric Balloon Mostly-Liquid Filled Device.
• Based on End Users, market is studied across Ambulatory Surgical Centers, Home Healthcare, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of obesity and related health conditions
    • 5.1.1.2. Supportive government policies and insurance coverage for bariatric surgeries and related treatments
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of bariatric procedures and products, along with limited awareness
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovations and investments in biotechnology and non-invasive treatments
    • 5.1.3.2. Expanding collaborations between healthcare providers and tech companies
  • 5.1.4. Challenges
    • 5.1.4.1. Risk of complications and side effects associated with bariatric procedures and products
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Rising usage of gastric electrical stimulation devices to control hunger and satiety
  • 5.2.2. End Users: Evolving usage of the bariatric products by the hospitals and clinics
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bariatric Products Market, by Product

• 6.1. Introduction
• 6.2. Gastric Balloons
• 6.3. Gastric Bands
• 6.4. Gastric Bypass Devices
• 6.5. Gastric Electrical Stimulation Devices
• 6.6. Gastric Emptying Devices

7. Bariatric Products Market, by Technology

• 7.1. Introduction
• 7.2. Adjustable Gastric Banding
• 7.3. Endoscopic Suturing Device
• 7.4. Gastric Positioning Device
• 7.5. Intragastric Balloon Mostly-Air Filled Device
• 7.6. Intragastric Balloon Mostly-Liquid Filled Device

8. Bariatric Products Market, by End Users

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Home Healthcare
• 8.4. Hospitals & Clinics

9. Americas Bariatric Products Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Bariatric Products Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Bariatric Products Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Allurion Technologies introduces AI-powered Virtual Care Suite in the US, aiming for enhanced weight-loss results and better patient engagement
  • 12.3.2. Reshape Lifesciences receives FDA PMA supplement approval for the Reshape Vest System, boosting global distribution and expanding minimally invasive obesity treatment options beyond the U.S.
  • 12.3.3. AdventHealth Redmond launches advanced metabolic and bariatric program to combat obesity and improve patient outcomes through innovative treatments and community engagement
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AMI GmbH
• 3. Apollo Endosurgery, Inc.
• 4. Asensus Surgical, Inc.
• 5. B. Braun SE
• 6. BIOTRONIK SE & Co KG
• 7. Boston Scientific Corporation
• 8. CONMED Corporation
• 9. Cousin Biotech
• 10. Edwards Lifesciences
• 11. Geyi Medical Instrument
• 12. GI Dynamics Inc.
• 13. Grena Ltd.
• 14. Integra LifeSciences Corporation
• 15. Intuitive Surgical Inc.
• 16. Johnson & Johnson Private Limited
• 17. Mediflex Surgical Products
• 18. Medtronic PLC
• 19. Olympus Corporation
• 20. ReShape Lifesciences, Inc.
• 21. Spatz FGIA, Inc.
• 22. Standard Bariatrics, Inc.
• 23. Stryker Corporation
• 24. USGI Medical Inc.
• 25. Zimmer Biomet Holdings, Inc.